Physicians’ Education Resources®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 1.5 Contact Hours.
This activity is supported by an educational grant from AstraZeneca.
New York Marriott Marquis
Julliard Complex (5th Floor)
New York, NY 10036
Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum will update oncology healthcare professionals involved in the treatment of patients with lung cancer by providing expert guidance, interpretation, and opinions on the importance and impact of liquid biopsy testing through multiple lines of therapy. This activity features 4 modules, which will present multiple expert points-of-view on this rapidly evolving area of molecular testing. In Module 1, the role of tumor genotyping in treatment decision making will be discussed, as well as the strengths and weaknesses of conventional tissue-based testing. Module 2 will outline the scientific basis for liquid-based molecular testing, including current data on the levels of concordance between liquid- and tissue-based genotyping. Module 3 will incorporate case-based discussion on the real-world application of liquid biopsies, including issues regarding turnaround time, sensitivity, and specificity. Module 4 will address outstanding questions and potential future applications of liquid-based biopsies.
This educational activity is intended for medical oncologists, pathologists, and fellows who treat patients with cancer, as well as nurse practitioners and nurses. Physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer will be invited to participate.
Upon completion of this activity, participants will be able to:
Benjamin Levy, MD
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
ASH: Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients with GvHD
December 8, 2017
ASH: Evaluating the Emerging Role of Biosimilar Agents for the Treatment of Hematologic Malignancies
December 8, 2017
Addressing Challenges and Personalizing Care in Postsurgical Pain Management - Brunch With the Experts
Dec 29, 2017